Black Friday Get Elite for just $149.00 Claim Now

Astronics Corporation Reports Record Operating Income on 28% Sales Growth for Third Quarter 2026

By Business Wire | November 10, 2026, 3:15 PM
  • Third quarter sales increased 28.5% to a record $271.7 million
  • Record operating income was $54.0 million, or 19.9% of sales; adjusted operating income1 was $51.0 million, or 18.8% of sales
  • Third quarter net income was $52.2 million, or $1.08 per diluted share; adjusted EBITDA1 was $59.3 million, or 21.8% of sales
  • Record Aerospace sales of $245.5 million delivered Aerospace operating margin of 23.4%; adjusted Aerospace operating margin1 was 22.5%
  • Quarterly bookings reached $271.1 million for book-to-bill of 1.00 and backlog was $780.0 million at quarter end; Aerospace book-to-bill at 1.05, over 1:1 for five consecutive quarters
  • Generated $25.8 million in cash from operations
  • Maintaining 2026 revenue guidance of $1.02 billion to $1.04 billion

EAST AURORA, N.Y.--(BUSINESS WIRE)--Astronics Corporation (Nasdaq: ATRO) (“Astronics” or the “Company”), a leading supplier of advanced technologies and products to the global aerospace, defense, and other mission critical industries, today reported financial results for the three and nine months ended October 3, 2026. Financial results include the acquisition of Bühler Motor Aviation (“BMA”) on October 13, 2025.



Peter J. Gundermann, Chairman, President and Chief Executive Officer, commented, “We delivered a strong third quarter, with record sales and operating income and an adjusted EBITDA margin near its all-time high. These results reflect disciplined operational execution and strong demand across our markets. Bookings were a solid $271.1 million following the prior quarter that had benefited from a couple of large program awards. We expect momentum to continue as we head into the final quarter of the year.”

Third Quarter Results

 

Three Months Ended

 

Nine Months Ended

($ in thousands)

October 3, 2026

 

September 27, 2025

 

% Change

 

October 3, 2026

 

September 27, 2025

 

% Change

 

 

 

 

 

 

 

 

 

 

 

 

Sales

$

271,679

 

 

$

211,447

 

 

28.5

%

 

$

762,255

 

 

$

622,061

 

 

22.5

%

Gross profit

$

93,974

 

 

$

64,511

 

 

45.7

%

 

$

256,004

 

 

$

178,187

 

 

43.7

%

Gross margin

 

34.6

%

 

 

30.5

%

 

 

 

 

33.6

%

 

 

28.6

%

 

 

Income from operations

$

53,983

 

 

$

23,055

 

 

134.1

%

 

$

121,680

 

 

$

40,950

 

 

197.1

%

Operating margin %

 

19.9

%

 

 

10.9

%

 

 

 

 

16.0

%

 

 

6.6

%

 

 

Loss on Settlement of Debt

$

—

 

 

$

32,644

 

 

 

 

$

—

 

 

$

32,644

 

 

 

Net income (loss)

$

52,204

 

 

$

(11,098

)

 

570.4

%

 

$

112,804

 

 

$

(256

)

 

44,164.1

%

Net income (loss) %

 

19.2

%

 

 

(5.2

)%

 

 

 

 

14.8

%

 

 

—

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted operating income2

$

50,968

 

 

$

25,931

 

 

96.6

%

 

$

123,754

 

 

$

66,833

 

 

85.2

%

Adjusted operating margin %2

 

18.8

%

 

 

12.3

%

 

 

 

 

16.2

%

 

 

10.7

%

 

 

Adjusted net income2

$

38,864

 

 

$

19,404

 

 

100.3

%

 

$

93,988

 

 

$

50,118

 

 

87.5

%

Adjusted EBITDA2

$

59,345

 

 

$

32,718

 

 

81.4

%

 

$

148,795

 

 

$

88,865

 

 

67.4

%

Adjusted EBITDA margin %2

 

21.8

%

 

 

15.5

%

 

 

 

 

19.5

%

 

 

14.3

%

 

 

Third Quarter 2026 Results (compared with the prior-year period, unless noted otherwise)

Growth in sales was driven by strong results in both the Aerospace and Test Systems segments. Aerospace sales increased $52.7 million, or 27.4%, while Test Systems sales grew $7.5 million, or 40.0%.

Gross profit increased $29.5 million to $94.0 million while gross margin expanded 410 basis points to 34.6% of sales. Gross profit growth and margin expansion were primarily attributable to higher volume, improved productivity, and $1.9 million in tariff refunds.

Selling, general and administrative expenses (“SG&A”) decreased $0.5 million. A favorable outcome in the UK patent infringement appeal resulted in a refund of approximately $4.4 million in damages and associated legal fees, and the Company received a $1.0 million favorable settlement from an unrelated matter. These benefits were largely offset by higher wages and benefits, higher incentive-based compensation expenses driven by increased profitability, and incremental expenses related to the acquired BMA business in 2025. R&D was down $0.9 million reflecting the timing of projects.

Operating margin expanded 900 basis points and adjusted operating margin2 expanded 650 basis points reflecting strong operating leverage from higher volume and improved productivity in the Aerospace segment. Operating profit and margin also benefited from improved performance in the Test Systems segment.

Interest expense was down $1.1 million, or 37.1%, on lower debt balances and reduced rates following the September 2025 refinancing activities. A tax benefit of $0.2 million was recorded on pretax income of $52 million for the quarter, as the benefit from a partial reversal of the valuation allowance, R&D tax credits, and the tax deductibility of R&D expenses more than offset the otherwise expected income tax expense.

Consolidated net income of $1.08 per diluted share improved from a net loss of $0.26 per diluted share in the prior-year period. The prior year’s net loss included the impact of a $32.6 million Loss on Settlement of Debt from certain costs incurred from the partial repurchase of convertible notes due in 2030.

Adjusted EBITDA2 increased 81.4% to $59.3 million, and adjusted EBITDA margin2 expanded 630 basis points to a record 21.8% of consolidated sales.

Bookings of $271.1 million in the quarter resulted in a book-to-bill ratio of 1.00:1. For the trailing twelve months, bookings totaled $1.12 billion and the book-to-bill ratio was 1.12:1. Backlog at the end of the quarter was $780.0 million.

Aerospace Segment Review (compared with the prior-year period, unless noted otherwise)

Aerospace segment sales of $245.5 million increased $52.7 million, or 27.4%. Sales in the Commercial Transport market increased $43.0 million, or 28.8%. Growth was primarily related to increased demand for inflight entertainment & connectivity (“IFEC”), seat motion and lighting and safety products. General Aviation sales increased $7.2 million, or 51.7%, to $21.1 million due to higher IFEC product sales. Military Aircraft sales increased $1.5 million, or 5.3%, to $29.0 million from higher sales of flight critical airframe power products.

Aerospace segment operating profit was $57.6 million, or 23.4% of sales, a 720 basis point improvement compared with the prior-year period. The improvement reflected operating leverage on higher volume, improved production efficiencies, $1.9 million in tariff refunds, and a $4.4 million benefit from the refund of litigation-related expenses and legal reserve adjustments related to the favorable outcome of the previously discussed UK patent dispute appeal. Adjusted Aerospace operating profit2 increased 71.5% to $55.1 million, or 22.5% of sales, a 580-basis point expansion over the comparator quarter.

Aerospace bookings were $258.3 million for a book-to-bill ratio of 1.05:1. Record backlog for the Aerospace segment was $670.0 million at quarter end.

Mr. Gundermann commented, “Our Aerospace business delivered excellent third quarter results, achieving record quarterly sales and a 22.5% adjusted operating margin. Growth was broad-based, led by strong demand across multiple product lines in Commercial Transport and continued strength in General Aviation. We ended the quarter with record Aerospace backlog of $670.0 million, reflecting the sustained strength of our order pipeline. We are very pleased by the trajectory of this business as we head into the fourth quarter.”

Test Systems Segment Review (compared with the prior-year period, unless noted otherwise)

Test Systems segment sales of $26.2 million were up $7.5 million from the comparator quarter in 2025 driven by strong order flow and production for the U.S. Army’s TS-4549/T Radio Test program. This was partially offset by a $2.2 million revision of estimated costs to complete certain long-term mass transit contracts which reduced revenue recognized in the period.

The TS-4549/T program drove $5.3 million of revenue in the quarter. The program is expected to reach full rate production in the first quarter of 2027.

Test Systems segment operating profit was $3.9 million, compared with near break-even in the third quarter of 2025.

Bookings for the Test Systems segment in the quarter were $12.8 million for a book-to-bill ratio of 0.49:1. Bookings over the last twelve months were $121.8 million for a book-to-bill of 1.41:1. Backlog for the Test Systems segment was $109.9 million at quarter end.

Mr. Gundermann commented, “Our Test business continued to build momentum in the third quarter, with improved operating profit as production on the U.S. Army's TS-4549/T Radio Test program progressed. We expect continued advancement on this program to drive further improvement in operating performance over the coming quarters, positioning the business for a strong 2027.”

Balance Sheet and Liquidity

Cash provided by operations in the third quarter of 2026 was $25.8 million, reflecting higher cash earnings offset by higher working capital requirements. Working capital increased due to higher receivables based on timing and increased inventory levels to support anticipated revenue growth in 2027. Capital expenditures in the quarter were $4.2 million and $21.1 million year-to-date. Elevated capital expenditures reflect necessary catch-up investments on previously deferred spending as well as the now completed consolidation of operations and capacity expansion in a new Seattle facility.

Long-term debt decreased $49.7 million to $284.8 million at October 3, 2026, compared with the end of 2025, and decreased $25.6 million from the end of the second quarter. The Company had available liquidity of $278.0 million at quarter-end, including $14.2 million in available cash and $263.8 million in availability on its revolver.

2026 Outlook

Astronics expects to set another annual sales record in 2026 with revenue estimated to be $1.02 billion to $1.04 billion for the year, representing growth of 19.5% over 2025 at the midpoint. Fourth quarter sales are expected to be $255 million to $275 million. Backlog at the end of the third quarter was $780.0 million, of which approximately 83% is expected to convert to revenue over the next twelve months.

Mr. Gundermann concluded, “We expect a solid fourth quarter to close out a year of strong growth and substantially improved profitability. While fourth quarter sales may be modestly lighter than the third quarter record level, our preliminary outlook for 2027 suggests another year of strong double digit growth. We are planning for a solid finish to this year and preparing for an exciting 2027.”

Planned capital expenditures in 2026 are expected to be in the range of $25 million to $30 million driven largely by costs associated with the Seattle operation consolidation, which concluded in the third quarter.

The Company estimates future IEEPA tariff refunds will range from $5 million to $6 million, although the timing of such receipts cannot be confirmed at this time.

Third Quarter 2026 Webcast and Conference Call

The Company will host a teleconference today at 4:45 p.m. ET. During the teleconference, management will review the financial and operating results for the period and discuss Astronics’ corporate strategy and outlook. A question-and-answer session will follow.

The Astronics conference call can be accessed by calling (201) 493-6784. The listen-only audio webcast can be monitored at investors.astronics.com. To listen to the archived call, dial (412) 317-6671 and enter replay pin number 13762682. The telephonic replay will be available from 8:00 p.m. on the day of the call through Tuesday, November 24, 2026. The webcast replay can be accessed via the investor relations section of the Company’s website where a transcript will also be posted once available.

About Astronics Corporation

Astronics Corporation (Nasdaq: ATRO) serves the world’s aerospace, defense, and other mission-critical industries with proven innovative technology solutions. Astronics works side-by-side with customers, integrating its array of power, connectivity, lighting, structures, interiors, and test technologies to solve complex challenges. For over 50 years, Astronics has delivered creative, customer-focused solutions with exceptional responsiveness. Today, global airframe manufacturers, airlines, military branches, completion centers, and Fortune 500 companies rely on the collaborative spirit and innovation of Astronics. The Company’s strategy is to increase its value by developing technologies and capabilities that provide innovative solutions to its targeted markets.

Safe Harbor Statement

This news release contains forward-looking statements as defined by the Securities Exchange Act of 1934. One can identify these forward-looking statements by the use of the words “expect,” “anticipate,” “plan,” “may,” “will,” “estimate,” “feeling” or other similar expressions and include all statements with regard to the momentum for the remainder of the year, the Company’s fourth quarter and full year 2026 outlook and expectations for similar growth rate in 2027, the degree of progress on the U.S. Army Radio Test Set program and the level of profitability improvement in the Test segment related to ramping the program up to full rate production, and the amount of tariff refunds to be received. The forward-looking statements also include all statements related to achieving any revenue or profitability expectations, expectations of continued growth, the level of liquidity, the level of cash generation and free cash flow, the level of demand by customers and markets and the amount of expected capital expenditures, the amount of investment in an ERP system, the amount of backlog to be recognized as revenue over the next twelve months, statements regarding the amount of opportunities available to be executed and the effectiveness of the Company’s execution in its operations. Because such statements apply to future events, they are subject to risks and uncertainties that could cause actual results to differ materially from those contemplated by the statements. Important factors that could cause actual results to differ materially from what may be stated here include the trend in growth with passenger power and connectivity on airplanes, the state of the aerospace and defense industries, commercial aircraft build rates, the market acceptance of newly developed products, internal production capabilities, the timing of orders received, the status of customer certification processes and delivery schedules, the demand for and market acceptance of new or existing aircraft which contain the Company’s products, the impact of regulatory activity, the need for new and advanced test equipment, customer preferences and relationships, the effectiveness of the Company’s supply chain and execution on opportunities, and other factors which are described in filings by Astronics with the Securities and Exchange Commission. Except as required by applicable law, the Company assumes no obligation to update forward-looking information in this news release whether to reflect changed assumptions, the occurrence of unanticipated events or changes in future operating results, financial conditions or prospects, or otherwise.

Use of Non-GAAP Financial Metrics and Additional Financial Information

In addition to reporting financial results in accordance with generally accepted accounting principles, or GAAP, Astronics provides Adjusted Non-GAAP information as additional information for its operating results. References to Adjusted Non-GAAP information are to non-GAAP financial measures. These measures are not required by, in accordance with, or an alternative for, GAAP and may be different from non-GAAP financial measures used by other companies. Astronics management uses these measures for reviewing the financial results of Astronics for budget planning purposes and for making operational and financial decisions. Management believes that providing these non-GAAP financial measures to investors, as a supplement to GAAP financial measures, help investors evaluate Astronics core operating and financial performance and business trends consistent with how management evaluates such performance and trends.

FINANCIAL TABLES FOLLOW

ASTRONICS CORPORATION

CONSOLIDATED STATEMENT OF OPERATIONS DATA

(Unaudited, $ in thousands except per share amounts)

 

 

 

 

 

 

Three Months Ended

 

Nine Months Ended

 

10/3/2026

 

9/27/2025

 

10/3/2026

 

9/27/2025

Sales

$

271,679

 

 

$

211,447

 

 

$

762,255

 

 

$

622,061

 

Cost of products sold

 

177,705

 

 

 

146,936

 

 

 

506,251

 

 

 

443,874

 

Gross profit

 

93,974

 

 

 

64,511

 

 

 

256,004

 

 

 

178,187

 

Gross margin

 

34.6

%

 

 

30.5

%

 

 

33.6

%

 

 

28.6

%

 

 

 

 

 

 

 

 

Research and development expenses

 

9,272

 

 

 

10,210

 

 

 

32,230

 

 

 

32,849

 

Selling, general and administrative

 

30,719

 

 

 

31,246

 

 

 

102,094

 

 

 

104,388

 

SG&A % of sales

 

11.3

%

 

 

14.8

%

 

 

13.4

%

 

 

16.8

%

Income from operations

 

53,983

 

 

 

23,055

 

 

 

121,680

 

 

 

40,950

 

Operating margin

 

19.9

%

 

 

10.9

%

 

 

16.0

%

 

 

6.6

%

 

 

 

 

 

 

 

 

Loss on settlement of debt

 

—

 

 

 

32,644

 

 

 

—

 

 

 

32,644

 

Other expense (income)

 

190

 

 

 

(185

)

 

 

580

 

 

 

(562

)

Interest expense, net

 

1,838

 

 

 

2,920

 

 

 

6,506

 

 

 

9,167

 

Income (loss) before tax

 

51,955

 

 

 

(12,324

)

 

 

114,594

 

 

 

(299

)

Income tax (benefit) expense

 

(249

)

 

 

(1,226

)

 

 

1,790

 

 

 

(43

)

Net income (loss)

$

52,204

 

 

$

(11,098

)

 

$

112,804

 

 

$

(256

)

Net income (loss) % of sales

 

19.2

%

 

 

(5.2

)%

 

 

14.8

%

 

 

—

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic earnings (loss) per share:3

$

1.21

 

 

$

(0.26

)

 

$

2.63

 

 

$

(0.01

)

 

 

 

 

 

 

 

 

Convertible notes interest expense, net

 

358

 

 

 

—

 

 

 

1,075

 

 

 

—

 

Net income (loss) - diluted

$

52,562

 

 

$

(11,098

)

 

$

113,879

 

 

$

(256

)

 

 

 

 

 

 

 

 

Diluted earnings (loss) per share:3, 4

$

1.08

 

 

$

(0.26

)

 

$

2.36

 

 

$

(0.01

)

 

 

 

 

 

 

 

 

Weighted average diluted shares outstanding (in thousands) 3, 4

 

48,531

 

 

 

42,507

 

 

 

48,170

 

 

 

42,447

 

ASTRONICS CORPORATION

CONSOLIDATED BALANCE SHEETS

($ in thousands)

 

(unaudited)

 

 

 

10/3/2026

 

12/31/2025

ASSETS

 

 

 

Cash and cash equivalents

$

7,925

 

 

$

18,180

 

Accounts receivable, net of allowance for estimated credit losses

 

256,994

 

 

 

204,672

 

Inventories

 

234,851

 

 

 

196,860

 

Prepaid expenses and other current assets

 

29,128

 

 

 

18,027

 

Total current assets

 

528,898

 

 

 

437,739

 

Property, plant and equipment, net of accumulated depreciation

 

115,790

 

 

 

107,078

 

Operating right-of-use assets

 

30,266

 

 

 

32,269

 

Other assets

 

16,496

 

 

 

11,316

 

Intangible assets, net of accumulated amortization

 

46,407

 

 

 

55,353

 

Goodwill

 

67,533

 

 

 

62,923

 

Total assets

$

805,390

 

 

$

706,678

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

Current liabilities:

 

 

 

Accounts payable

$

69,911

 

 

$

41,080

 

Current operating lease liabilities

 

5,928

 

 

 

5,802

 

Accrued expenses and other current liabilities

 

75,464

 

 

 

68,324

 

Customer advances and deferred revenue

 

28,534

 

 

 

26,069

 

Total current liabilities

 

179,837

 

 

 

141,275

 

Long-term debt

 

284,753

 

 

 

334,451

 

Long-term operating lease liabilities

 

35,478

 

 

 

38,101

 

Other liabilities

 

49,866

 

 

 

52,777

 

Total liabilities

 

549,934

 

 

 

566,604

 

Shareholders’ equity:5

 

 

 

Common stock

 

459

 

 

 

456

 

Accumulated other comprehensive loss

 

(6,776

)

 

 

(4,410

)

Other shareholders’ equity

 

261,773

 

 

 

144,028

 

Total shareholders’ equity

 

255,456

 

 

 

140,074

 

Total liabilities and shareholders’ equity

$

805,390

 

 

$

706,678

 

ASTRONICS CORPORATION

CONSOLIDATED CASH FLOWS DATA

 

 

 

 

 

Nine Months Ended

(Unaudited, $ in thousands)

10/3/2026

 

9/27/2025

Cash flows from operating activities:

 

 

 

Net income (loss)

$

112,804

 

 

$

(256

)

Adjustments to reconcile net income (loss) to cash from operating activities:

 

 

 

Non-cash items:

 

 

 

Depreciation and amortization

 

18,538

 

 

 

16,129

 

Amortization of deferred financing fees

 

1,800

 

 

 

1,805

 

Provisions for non-cash losses on inventory and receivables

 

4,663

 

 

 

6,062

 

Equity-based compensation expense

 

7,083

 

 

 

5,341

 

Deferred tax expense (benefit)

 

1,001

 

 

 

(1,125

)

Loss on settlement of debt

 

—

 

 

 

32,644

 

Operating lease non-cash expense

 

4,029

 

 

 

4,659

 

Simplification initiative-related non-cash charges

 

—

 

 

 

6,229

 

Other

 

1,945

 

 

 

(756

)

Cash flows from changes in operating assets and liabilities:

 

 

 

Accounts receivable

 

(53,793

)

 

 

5,190

 

Inventories

 

(43,628

)

 

 

(7,140

)

Accounts payable

 

29,265

 

 

 

8,271

 

Operating lease liabilities

 

(4,566

)

 

 

(3,125

)

Accrued expenses

 

2,463

 

 

 

(14,719

)

Income taxes

 

(55

)

 

 

(11,513

)

Tenant improvement allowance refund

 

—

 

 

 

3,157

 

Cloud computing implementation costs

 

(7,442

)

 

 

—

 

Customer advance payments and deferred revenue

 

2,358

 

 

 

(2,317

)

Supplemental retirement plan liabilities

 

(545

)

 

 

(539

)

Other assets and liabilities

 

(9,346

)

 

 

(825

)

Net cash provided by operating activities

 

66,574

 

 

 

47,172

 

Cash flows from investing activities:

 

 

 

Capital expenditures

 

(21,071

)

 

 

(19,860

)

Acquisition of business, net of cash acquired

 

—

 

 

 

(4,617

)

Net cash used by investing activities

 

(21,071

)

 

 

(24,477

)

Cash flows from financing activities:

 

 

 

Proceeds from long-term debt

 

44,000

 

 

 

86,143

 

Principal payments on long-term debt

 

(95,000

)

 

 

(11,143

)

Proceeds from issuance of convertible debt

 

—

 

 

 

225,000

 

Partial repurchase of 2030 notes

 

—

 

 

 

(285,752

)

Payments for capped call transactions

 

—

 

 

 

(26,888

)

Financing-related costs

 

—

 

 

 

(8,127

)

Stock award activity

 

(2,007

)

 

 

(1,730

)

Other

 

(2,241

)

 

 

(109

)

Net cash used by financing activities

 

(55,248

)

 

 

(22,606

)

Effect of exchange rates on cash

 

(510

)

 

 

1,063

 

(Decrease) increase in cash and cash equivalents and restricted cash

 

(10,255

)

 

 

1,152

 

Cash and cash equivalents and restricted cash at beginning of period

 

18,180

 

 

 

18,428

 

Cash and cash equivalents and restricted cash at end of period

$

7,925

 

 

$

19,580

 

 

 

 

 

Supplemental disclosure of cash flow information

 

 

 

Capital expenditures in accounts payable (non-cash investing activities)

$

—

 

 

$

2,796

 

Interest paid

$

5,683

 

 

$

7,593

 

Income taxes paid, net

$

814

 

 

$

12,636

 

ASTRONICS CORPORATION

SEGMENT SALES AND PROFIT

(Unaudited, $ in thousands)

 

 

 

 

Three Months Ended

 

Nine Months Ended

 

10/3/2026

 

9/27/2025

 

10/3/2026

 

9/27/2025

Sales

 

 

 

 

 

 

 

Aerospace

$

245,573

 

 

$

192,725

 

 

$

696,708

 

 

$

577,760

 

Less inter-segment

 

(101

)

 

 

—

 

 

 

(124

)

 

 

(34

)

Total Aerospace

 

245,472

 

 

 

192,725

 

 

 

696,584

 

 

 

577,726

 

 

 

 

 

 

 

 

 

Test Systems

 

26,212

 

 

 

18,752

 

 

 

65,710

 

 

 

44,685

 

Less inter-segment

 

(5

)

 

 

(30

)

 

 

(39

)

 

 

(350

)

Total Test Systems

 

26,207

 

 

 

18,722

 

 

 

65,671

 

 

 

44,335

 

 

 

 

 

 

 

 

 

Total consolidated sales

 

271,679

 

 

 

211,447

 

 

 

762,255

 

 

 

622,061

 

 

 

 

 

 

 

 

 

Segment gross profit and margins

 

 

 

 

 

 

 

Aerospace

 

85,746

 

 

 

60,462

 

 

 

238,591

 

 

 

173,836

 

 

 

34.9

%

 

 

31.4

%

 

 

34.3

%

 

 

30.1

%

Test Systems

 

8,228

 

 

 

4,049

 

 

 

17,413

 

 

 

4,351

 

 

 

31.4

%

 

 

21.6

%

 

 

26.5

%

 

 

9.8

%

Total gross profit

 

93,974

 

 

 

64,511

 

 

 

256,004

 

 

 

178,187

 

 

 

34.6

%

 

 

30.5

%

 

 

33.6

%

 

 

28.6

%

Segment operating profit and margins

 

 

 

 

 

 

 

Aerospace

 

57,559

 

 

 

31,167

 

 

 

141,155

 

 

 

71,470

 

 

 

23.4

%

 

 

16.2

%

 

 

20.3

%

 

 

12.4

%

Test Systems

 

3,851

 

 

 

(14

)

 

 

4,846

 

 

 

(8,947

)

 

 

14.7

%

 

 

(0.1

)%

 

 

7.4

%

 

 

(20.2

)%

Total segment operating profit

 

61,410

 

 

 

31,153

 

 

 

146,001

 

 

 

62,523

 

 

 

 

 

 

 

 

 

Loss on settlement of debt

 

—

 

 

 

32,644

 

 

 

—

 

 

 

32,644

 

Interest expense

 

1,838

 

 

 

2,920

 

 

 

6,506

 

 

 

9,167

 

Corporate expenses and other

 

7,617

 

 

 

7,913

 

 

 

24,901

 

 

 

21,011

 

Income (loss) before taxes

$

51,955

 

 

$

(12,324

)

 

$

114,594

 

 

$

(299

)

ASTRONICS CORPORATION

SALES BY MARKET

(Unaudited, $ in thousands)

 

 

 

 

 

 

Three Months Ended

Nine Months Ended

2026 YTD
% of Sales

10/3/2026

9/27/2025

% Change

10/3/2026

9/27/2025

% Change

Aerospace Segment

 

 

 

 

 

 

 

 

Commercial Transport

$

192,243

$

149,209

28.8

%

 

$

525,668

$

432,324

21.6

%

69.0

%

Military Aircraft

 

29,028

 

27,554

5.3

%

 

 

93,161

 

88,250

5.6

%

12.2

%

General Aviation

 

21,121

 

13,919

51.7

%

 

 

70,173

 

47,532

47.6

%

9.2

%

Other

 

3,080

 

2,043

50.8

%

 

 

7,582

 

9,620

(21.2

)%

1.0

%

Aerospace Total

 

245,472

 

192,725

27.4

%

 

 

696,584

 

577,726

20.6

%

91.4

%

 

 

 

 

 

 

 

 

 

Test Systems Segment

 

 

 

 

 

 

 

 

Government & Defense

 

26,207

 

18,722

40.0

%

 

 

65,671

 

44,335

48.1

%

8.6

%

 

 

 

 

 

 

 

 

 

Total Sales

$

271,679

$

211,447

28.5

%

 

$

762,255

$

622,061

22.5

%

 


Contacts

For more information, contact:
Company:
Nancy L. Hedges, Chief Financial Officer
Phone: (716) 805-1599
Email: invest@astronics.com

Investor Relations:
Deborah K. Pawlowski, Alliance Advisors LLC
Phone: (716) 843-3908
Email: dpawlowski@allianceadvisors.com


Read full story here

Mentioned In This Article

Latest News

Nov-10
Nov-10
Nov-10
Nov-03
Oct-28
Sep-08
Aug-31
Aug-12
Aug-12
Aug-12
Aug-11
Jul-28
Jul-27
Jun-29
Jun-01